These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10967203)

  • 21. Effects of tGLP-1 on feeding behaviour and neurohypophysial function under chronic osmotic stimulation.
    Bojanowska E; Stempniak B
    Physiol Behav; 2003 Jan; 78(1):73-9. PubMed ID: 12536013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of neosurugatoxin on the release of neurohypophysial hormones by nicotine, hypotension and an osmotic stimulus in the rat.
    Bisset GW; Fairhall KM; Tsuji K
    Br J Pharmacol; 1992 Jul; 106(3):685-92. PubMed ID: 1504751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of central injection of kyotorphin and L-arginine on oxytocin and vasopressin release and blood pressure in conscious rats.
    Summy-Long JY; Bui V; Gestl S; Koehler-Stec E; Liu H; Terrell ML; Kadekaro M
    Brain Res Bull; 1998; 45(4):395-403. PubMed ID: 9527014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM.
    Gutniak MK; Linde B; Holst JJ; Efendić S
    Diabetes Care; 1994 Sep; 17(9):1039-44. PubMed ID: 7988303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
    Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R
    Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of glucagon-like peptide 1 (7-36) amide and glucagon on amylin release from perfused rat pancreas.
    Inoue K; Hisatomi A; Umeda F; Nawata H
    Horm Metab Res; 1991 Sep; 23(9):407-9. PubMed ID: 1743611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats.
    Schick RR; Zimmermann JP; vorm Walde T; Schusdziarra V
    Am J Physiol Regul Integr Comp Physiol; 2003 Jun; 284(6):R1427-35. PubMed ID: 12776726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats.
    Davis HR; Mullins DE; Pines JM; Hoos LM; France CF; Compton DS; Graziano MP; Sybertz EJ; Strader CD; Van Heek M
    Obes Res; 1998 Mar; 6(2):147-56. PubMed ID: 9545022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galanin affects vasopressin and oxytocin release from the hypothalamo-neurohypophysial system in haemorrahaged rats.
    Ciosek J; Cisowska A; Dabrowski R
    J Physiol Pharmacol; 2003 Jun; 54(2):233-46. PubMed ID: 12832724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GLP-1 does not not acutely affect insulin sensitivity in healthy man.
    Orskov L; Holst JJ; Møller J; Orskov C; Møller N; Alberti KG; Schmitz O
    Diabetologia; 1996 Oct; 39(10):1227-32. PubMed ID: 8897012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous glucagon-like peptide-1 (7-36) amide is insulinotropic and can cause hypoglycaemia in fasted healthy subjects.
    Edwards CM; Todd JF; Ghatei MA; Bloom SR
    Clin Sci (Lond); 1998 Dec; 95(6):719-24. PubMed ID: 9831697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A synthetic glucagon-like peptide-1 analog with improved plasma stability.
    Ritzel U; Leonhardt U; Ottleben M; Rühmann A; Eckart K; Spiess J; Ramadori G
    J Endocrinol; 1998 Oct; 159(1):93-102. PubMed ID: 9795346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitric oxide control of drinking, vasopressin and oxytocin release and blood pressure in dehydrated rats.
    Liu H; Terrell ML; Bui V; Summy-Long JY; Kadekaro M
    Physiol Behav; 1998 Mar; 63(5):763-9. PubMed ID: 9617997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.
    Nauck MA; Niedereichholz U; Ettler R; Holst JJ; Orskov C; Ritzel R; Schmiegel WH
    Am J Physiol; 1997 Nov; 273(5):E981-8. PubMed ID: 9374685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients.
    Herrmann C; Göke R; Richter G; Fehmann HC; Arnold R; Göke B
    Digestion; 1995; 56(2):117-26. PubMed ID: 7750665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7--36) amide.
    Heller RS; Aponte GW
    Am J Physiol; 1995 Dec; 269(6 Pt 1):G852-60. PubMed ID: 8572216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of the rat mesolimbic dopaminergic system produces a pressor response which is mediated by dopamine D-1 and D-2 receptor activation and the release of vasopressin.
    Cornish JL; van den Buuse M
    Brain Res; 1995 Dec; 701(1-2):28-38. PubMed ID: 8925292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of centrally-injected glucagon-like peptide-1 on pilocarpine-induced seizures, anxiety and locomotor and exploratory activity in rat.
    Gulec G; Isbil-Buyukcoskun N; Kahveci N
    Neuropeptides; 2010 Aug; 44(4):285-91. PubMed ID: 20227110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line.
    Beak SA; Heath MM; Small CJ; Morgan DG; Ghatei MA; Taylor AD; Buckingham JC; Bloom SR; Smith DM
    J Clin Invest; 1998 Mar; 101(6):1334-41. PubMed ID: 9502775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Centrally administered galanin modifies vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of euhydrated and dehydrated rats.
    Ciosek J; Cisowska A
    J Physiol Pharmacol; 2003 Dec; 54(4):625-41. PubMed ID: 14726616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.